Top 10 Human Anti Rabies Vaccine Manufacturers

May 31, 2024

The human anti-rabies vaccine consumer market is expected to grow due to increasing awareness about the importance of Rabies Prevention. With rising cases of rabies worldwide, the demand for the vaccine is on the rise. The market is driven by government initiatives, healthcare infrastructure development, and growing investments in research and development. Major players in the market include Sanofi Pasteur, GlaxoSmithKline, and Merck & Co. The market is expected to witness significant growth in the coming years as more countries prioritize rabies prevention programs.

Sanofi Pasteur
GlaxoSmithKline
Merck & Co.
Bharat Biotech
Changchun Zhuoyi Biological Co., Ltd
Serum Institute of India

Sanofi Pasteur

Establishment time : 1970

website : www.sanofipasteur.com

Main Product : Vaccines

Company Profile

Sanofi Pasteur is the vaccines division of Sanofi, dedicated to preventing disease through vaccination. With a long history of innovation and expertise in vaccine production, Sanofi Pasteur is a trusted leader in the global healthcare industry.

GlaxoSmithKline

Establishment time : GlaxoSmithKline is a leading healthcare company that focuses on improving the quality of human life by developing innovative medicines and healthcare products.

website :

Main Product : The company's diverse portfolio includes a wide range of prescription medicines, vaccines, and consumer healthcare products that address a variety of health conditions.

Company Profile

Overall, GlaxoSmithKline is a trusted and respected company that continues to drive innovation and make a difference in the healthcare industry.

Merck & Co.

Establishment time : Merck & Co. is a leading pharmaceutical company with a long history of innovation and research.

website :

Main Product : Merck & Co. has a strong presence in the global market, with a diverse portfolio of products.

Company Profile

Merck & Co. remains a trusted and respected name in the pharmaceutical industry.

Bharat Biotech

Establishment time : Bharat Biotech was founded in 1996.

website :

Main Product : Bharat Biotech is a leading vaccine manufacturer in India.

Company Profile

Bharat Biotech is committed to improving global health through its vaccines.

Changchun Zhuoyi Biological Co., Ltd

Establishment time : 2005

website : www1.zhuoyi-bio.com

Main Product : Human Rabies Vaccine,Rabies Prevention ,Freeze-dried Human Rabies Vaccine ,Rabies Vaccine,Human Rabies Vaccination,Human Rabies Vaccine and Infant

Company Profile

Changchun Zhuoyi Biological Co., Ltd., located in Shuangyang Economic Development Zone of Changchun City, is a key vaccine manufacturer invested by Zhejiang SelCorning Biotechnology Co., Ltd. in Jilin Province, and a vice chairman unit of Zhejiang Chamber of Commerce in Jilin Province. The company was founded on January 27, 2005. Mr. Feng Xingfu, chairman and general manager of the company, graduated from the Department of Biology, University of Science and Technology of China, and has been engaged in the marketing and enterprise management of biological products since the 1980s. The company has a registered capital of one hundred and one million six hundred and ninety-two thousand seven hundred and eighty-four yuan, covers an area of 41600 square meters, and has the leading vaccine research and development and production capacity in China. Changchun Zhuoyi Biological Co., Ltd. is a new vaccine manufacturer integrating R&D, production and sales. At present, the biological products approved by the company are mainly Rabies Vaccine (Vero cell) for Human Use, Freeze-dried. The company successfully passed the two in one inspection at the end of 2016 and obtained the registration approval and GMP certificate, which was officially put into production in January 2017. The company's existing production workshop covers an area of about 5700 square meters, with a cumulative investment of 400 million yuan. At present, the maximum annual output is 1 million people. The second phase workshop has been completed at the end of 2018, and will be officially produced in 2020. By then, the production capacity can reach 4 million people. The company has nearly 2000 square meters of pilot scale research workshop, advanced equipment such as bioreactor, ultrafiltration system, AKTA purification workstation, fluorescence microscope, etc., which are used for virus culture, improvement of purification system and identification of recombinant protein. The company has maintained close scientific research cooperation with many scientific research institutions at home and abroad. At present, the company is developing a serum rabies vaccine and a broad-spectrum human papillomavirus vaccine jointly developed with the Institute of Basic Medicine of the Chinese Academy of Medical Sciences. It is planned to cooperate with Murdoch Children's Research Institute in Australia to develop the round vaccine project. At the same time, the company also actively explores the path of internationalization. At present, the company has started to register in the Philippines, Pakistan, Cambodia, Bangladesh, Mongolia, Uzbekistan and other countries. It is estimated that the export of finished products in some markets will be realized by 2020. The company's technical cooperation project with Australia is one of the company's many international cooperation projects. The company always adheres to the concept of "standardized management, quality first", and adheres to the core values of "honesty, diligence, innovation, preciseness, learning and happiness", so as to provide high-quality vaccine products to serve the health of the people.

Serum Institute of India

Establishment time : The Serum Institute of India was founded in 1966 with the aim of manufacturing life-saving vaccines at affordable prices.

website :

Main Product : The company is known for its high-quality products and commitment to global health.

Company Profile

As a pioneer in the field of vaccine production, the company continues to innovate and expand its product portfolio to address emerging health challenges.

Author:

Mr. Simba Li

E-mail:

lixuejian@zy-bio.cn

Phone/WhatsApp:

+86 18946525326